Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bas de Laat

Showing results (91-100 of 182) with videos related to

Pageof 19
Sort By:
Journal of Thrombosis and Haemostasis : JTH|February 4, 2026
Thrombin generation and thrombin dynamics are associated with recurrent venous thromboembolism after anticoagulation withdrawalGeke C Poolen, Romy M W de Laat-Kremers, Mark Roest, et al.
Plos One|October 29, 2015
Thrombin Generating Capacity and Phenotypic Association in ABO Blood GroupsRomy M W Kremers, Abdulrahman B O Mohamed, Leonie Pelkmans, et al.
Plos One|May 5, 2017
Decreased prothrombin conversion and reduced thrombin inactivation explain rebalanced thrombin generation in liver cirrhosisRomy M W Kremers, Marie-Claire Kleinegris, Marisa Ninivaggi, et al.
Blood|August 27, 2009
Association between beta2-glycoprotein I plasma levels and the risk of myocardial infarction in older menBas de Laat, Philip G de Groot, Ronald H W M Derksen, et al.
Journal of Thrombosis and Haemostasis : JTH|September 14, 2019
The (non-)sense of detecting anti-cardiolipin and anti-β2glycoprotein I IgM antibodies in the antiphospholipid syndromeWalid Chayoua, Hilde Kelchtermans, Jean-Christophe Gris, et al.
Thrombosis Research|December 22, 2023
Low factor XIII levels and altered fibrinolysis in patients with multiple myelomaHarriet Ghansah, Rita Orbán-Kálmándi, Ildikó Beke Debreceni, et al.
Blood Vessels, Thrombosis & Hemostasis|October 16, 2025
Procoagulant off-target effect of the direct oral anticoagulant reversal agent Andexanet alfaIscha M S Hoornstra, Junxiong Zhao, Harmen Middelveld, et al.
Journal of Pediatric Hematology/Oncology|April 7, 2009
A novel type 2A von Willebrand factor mutation (V1499E) associated with variable clinical expressionEsther van den Heuvel, Bas de Laat, Carel M Eckmann, et al.
Plos One|February 14, 2019
Analytical characterization and reference interval of an enzyme-linked immunosorbent assay for active von Willebrand factorLisa N van der Vorm, Li Li, Dana Huskens, et al.
Research and Practice in Thrombosis and Haemostasis|August 7, 2024
Interference of lupus anticoagulant causing antiprothrombin and anti-beta-2-glycoprotein I antibodies on international normalized ratio measurements: comparative analysis of international normalized ratio methodsRachel Gehlen, Roxanne G Moesbergen, CuiCui Bai, et al.
Pageof 19

Showing results (91-100 of 182) with videos related to

Sort By:
Pageof 19
Journal of Thrombosis and Haemostasis : JTH|February 4, 2026
Thrombin generation and thrombin dynamics are associated with recurrent venous thromboembolism after anticoagulation withdrawalGeke C Poolen, Romy M W de Laat-Kremers, Mark Roest, et al.
Plos One|October 29, 2015
Thrombin Generating Capacity and Phenotypic Association in ABO Blood GroupsRomy M W Kremers, Abdulrahman B O Mohamed, Leonie Pelkmans, et al.
Plos One|May 5, 2017
Decreased prothrombin conversion and reduced thrombin inactivation explain rebalanced thrombin generation in liver cirrhosisRomy M W Kremers, Marie-Claire Kleinegris, Marisa Ninivaggi, et al.
Blood|August 27, 2009
Association between beta2-glycoprotein I plasma levels and the risk of myocardial infarction in older menBas de Laat, Philip G de Groot, Ronald H W M Derksen, et al.
Journal of Thrombosis and Haemostasis : JTH|September 14, 2019
The (non-)sense of detecting anti-cardiolipin and anti-β2glycoprotein I IgM antibodies in the antiphospholipid syndromeWalid Chayoua, Hilde Kelchtermans, Jean-Christophe Gris, et al.
Thrombosis Research|December 22, 2023
Low factor XIII levels and altered fibrinolysis in patients with multiple myelomaHarriet Ghansah, Rita Orbán-Kálmándi, Ildikó Beke Debreceni, et al.
Blood Vessels, Thrombosis & Hemostasis|October 16, 2025
Procoagulant off-target effect of the direct oral anticoagulant reversal agent Andexanet alfaIscha M S Hoornstra, Junxiong Zhao, Harmen Middelveld, et al.
Journal of Pediatric Hematology/Oncology|April 7, 2009
A novel type 2A von Willebrand factor mutation (V1499E) associated with variable clinical expressionEsther van den Heuvel, Bas de Laat, Carel M Eckmann, et al.
Plos One|February 14, 2019
Analytical characterization and reference interval of an enzyme-linked immunosorbent assay for active von Willebrand factorLisa N van der Vorm, Li Li, Dana Huskens, et al.
Research and Practice in Thrombosis and Haemostasis|August 7, 2024
Interference of lupus anticoagulant causing antiprothrombin and anti-beta-2-glycoprotein I antibodies on international normalized ratio measurements: comparative analysis of international normalized ratio methodsRachel Gehlen, Roxanne G Moesbergen, CuiCui Bai, et al.
Pageof 19